Cargando…

Long-term efficacy, safety and durability of Juvéderm® XC

Over the last decade, there has been increasing interest in minimally invasive cosmetic treatments, especially for facial rejuvenation. Next to botulinum toxin injection, the injection of soft tissue fillers is the second most frequent minimally invasive procedure performed in the USA. Hyaluronic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballin, Annelyse C, Cazzaniga, Alex, Brandt, Fredric S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739705/
https://www.ncbi.nlm.nih.gov/pubmed/23946665
http://dx.doi.org/10.2147/CCID.S33568
_version_ 1782476941429833728
author Ballin, Annelyse C
Cazzaniga, Alex
Brandt, Fredric S
author_facet Ballin, Annelyse C
Cazzaniga, Alex
Brandt, Fredric S
author_sort Ballin, Annelyse C
collection PubMed
description Over the last decade, there has been increasing interest in minimally invasive cosmetic treatments, especially for facial rejuvenation. Next to botulinum toxin injection, the injection of soft tissue fillers is the second most frequent minimally invasive procedure performed in the USA. Hyaluronic acid (HA) is the most commonly used dermal filler. One of patients’ main concerns about filler injections pertains to pain and discomfort. Topical anesthetics, nerve blocks, and/or the incorporation of lidocaine to the filler have been applied in order to reduce distress and pain. Despite nerve blocks being an effective form of anesthesia, they may distort the area to be treated, as well as lengthen and complicate the procedure. Studies have shown that the incorporation of lidocaine to HA fillers significantly reduces pain and discomfort. Yet, one of the dilemmas about the addition of lidocaine solution to HA fillers is the possible alteration of the physical characteristics of the product by negatively impacting the efficacy and/or duration of the filler. The concern is that the addition of lidocaine could dilute the product, creating less correction per mL, changing the product’s viscosity and consequently the “lifting” ability. Also, this dilution could reduce the product’s duration. There may be a difference between a physician adding an aqueous solution into a lidocaine-free version of HA and the pre-incorporated lidocaine version of HA. An aqueous solution might dilute the product, while the pre-incorporated powder lidocaine appears to avoid this problem. Juvéderm® XC is manufactured with powder lidocaine 0.3%; it is associated with significantly less injection pain than Juvéderm® and other lidocaine-free versions of HA. Studies have shown that lidocaine enhances treatment comfort and optimizes the injection experience while maintaining a similar safety and effectiveness profile. Regarding the longevity, further study is necessary to determine if there is any difference in durability.
format Online
Article
Text
id pubmed-3739705
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37397052013-08-14 Long-term efficacy, safety and durability of Juvéderm® XC Ballin, Annelyse C Cazzaniga, Alex Brandt, Fredric S Clin Cosmet Investig Dermatol Review Over the last decade, there has been increasing interest in minimally invasive cosmetic treatments, especially for facial rejuvenation. Next to botulinum toxin injection, the injection of soft tissue fillers is the second most frequent minimally invasive procedure performed in the USA. Hyaluronic acid (HA) is the most commonly used dermal filler. One of patients’ main concerns about filler injections pertains to pain and discomfort. Topical anesthetics, nerve blocks, and/or the incorporation of lidocaine to the filler have been applied in order to reduce distress and pain. Despite nerve blocks being an effective form of anesthesia, they may distort the area to be treated, as well as lengthen and complicate the procedure. Studies have shown that the incorporation of lidocaine to HA fillers significantly reduces pain and discomfort. Yet, one of the dilemmas about the addition of lidocaine solution to HA fillers is the possible alteration of the physical characteristics of the product by negatively impacting the efficacy and/or duration of the filler. The concern is that the addition of lidocaine could dilute the product, creating less correction per mL, changing the product’s viscosity and consequently the “lifting” ability. Also, this dilution could reduce the product’s duration. There may be a difference between a physician adding an aqueous solution into a lidocaine-free version of HA and the pre-incorporated lidocaine version of HA. An aqueous solution might dilute the product, while the pre-incorporated powder lidocaine appears to avoid this problem. Juvéderm® XC is manufactured with powder lidocaine 0.3%; it is associated with significantly less injection pain than Juvéderm® and other lidocaine-free versions of HA. Studies have shown that lidocaine enhances treatment comfort and optimizes the injection experience while maintaining a similar safety and effectiveness profile. Regarding the longevity, further study is necessary to determine if there is any difference in durability. Dove Medical Press 2013-08-05 /pmc/articles/PMC3739705/ /pubmed/23946665 http://dx.doi.org/10.2147/CCID.S33568 Text en © 2013 Ballin et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Ballin, Annelyse C
Cazzaniga, Alex
Brandt, Fredric S
Long-term efficacy, safety and durability of Juvéderm® XC
title Long-term efficacy, safety and durability of Juvéderm® XC
title_full Long-term efficacy, safety and durability of Juvéderm® XC
title_fullStr Long-term efficacy, safety and durability of Juvéderm® XC
title_full_unstemmed Long-term efficacy, safety and durability of Juvéderm® XC
title_short Long-term efficacy, safety and durability of Juvéderm® XC
title_sort long-term efficacy, safety and durability of juvéderm® xc
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739705/
https://www.ncbi.nlm.nih.gov/pubmed/23946665
http://dx.doi.org/10.2147/CCID.S33568
work_keys_str_mv AT ballinannelysec longtermefficacysafetyanddurabilityofjuvedermxc
AT cazzanigaalex longtermefficacysafetyanddurabilityofjuvedermxc
AT brandtfredrics longtermefficacysafetyanddurabilityofjuvedermxc